Technology

Fighting Cancer With Magnetic Bacteria

Magnetic Bacteria

Magnetic bacteria (grey) can squeeze through narrow intercellular spaces to cross the blood vessel wall and infiltrate tumors. Credit: Yimo Yan / ETH Zurich

Researchers are working to determine the best way for anti-cancer drugs to get to the tumors they are supposed to treat. One option is to utilize modified bacteria as “ferries” to transport the drugs to the tumors via the bloodstream. ETH Zurich researchers have now successfully controlled some bacteria such that they may pass the blood vessel wall and infiltrate tumor tissue.

The ETH Zurich researchers, led by Simone Schürle, Professor of Responsive Biomedical Systems, opted to experiment with bacteria that are inherently magnetic owing to the iron oxide particles they contain. These Magnetospirillum bacteria react to magnetic fields and can be manipulated by external magnets.

Exploiting temporary gaps

Schürle and her colleagues have now shown in cell cultures and mice that applying a rotating magnetic field to the tumor boosts the bacteria’s ability to cross the vascular wall around the cancerous growth. The rotating magnetic field drives the bacteria ahead in a circular motion at the vascular wall.

To better understand the mechanism to cross the vessel wall works, a detailed look is necessary: The blood vessel wall consists of a layer of cells and serves as a barrier between the bloodstream and the tumor tissue, which is permeated by many small blood vessels. Narrow spaces between these cells allow certain molecules to pass through the vessel wall. How large these intercellular spaces are is regulated by the cells of the vessel wall, and they can be temporarily wide enough to allow even bacteria to pass through the vessel wall.

Strong propulsion and high probability

With the help of experiments and computer simulations, the ETH Zurich researchers were able to show that propelling the bacteria using a rotating magnetic field is effective for three reasons. First, propulsion via a rotating magnetic field is ten times more powerful than propulsion via a static magnetic field. The latter merely sets the direction and the bacteria have to move under their own power.

The second and most critical reason is that bacteria driven by the rotating magnetic field are constantly in motion, traveling along the vascular wall. This makes them more likely to encounter the gaps that briefly open between vessel wall cells compared to other propulsion types, in which the bacteria’s motion is less explorative. And third, unlike other methods, the bacteria do not need to be tracked via imaging. Once the magnetic field is positioned over the tumor, it does not need to be readjusted.

“Cargo” accumulates in tumor tissue

“We make use of the bacteria’s natural and autonomous locomotion as well,” Schürle explains. “Once the bacteria have passed through the blood vessel wall and are in the tumor, they can independently migrate deep into its interior.” For this reason, the scientists use the propulsion via the external magnetic field for just one hour – long enough for the bacteria to efficiently pass through the vascular wall and reach the tumor.

Such bacteria could carry anti-cancer drugs in the future. In their cell culture studies, the ETH Zurich researchers simulated this application by attaching liposomes (nanospheres of fat-like substances) to the bacteria. They tagged these liposomes with a fluorescent dye, which allowed them to demonstrate in the Petri dish that the bacteria had indeed delivered their “cargo” inside the cancerous tissue, where it accumulated. In future medical applications, the liposomes would be filled with a drug.

Bacterial cancer therapy

Using bacteria as ferries for drugs is one of two ways that bacteria can help in the fight against cancer. The other approach is over a hundred years old and currently experiencing a revival: using the natural propensity of certain species of bacteria to damage tumor cells. This may involve several mechanisms. In any case, it is known that the bacteria stimulate certain cells of the immune system, which then eliminate the tumor.

Multiple research projects are currently investigating the efficacy of E. coli bacteria against tumors. Today, it is possible to modify bacteria using synthetic biology to optimize their therapeutic effect, reduce side effects, and make them safer.

Making non-magnetic bacteria magnetic

Yet to use the inherent properties of bacteria in cancer therapy, the question of how these bacteria can reach the tumor efficiently still remains. While it is possible to inject the bacteria directly into tumors near the surface of the body, this is not possible for tumors deep inside the body. That is where Professor Schürle’s microrobotic control comes in. “We believe we can use our engineering approach to increase the efficacy of bacterial cancer therapy,” she says.

E. coli used in the cancer studies is not magnetic and thus cannot be propelled and controlled by a magnetic field. In general, magnetic responsiveness is a very rare phenomenon among bacteria. Magnetospirillum is one of the few genera of bacteria that have this property.

Schürle, therefore, wants to make E. coli bacteria magnetic as well. This could one day make it possible to use a magnetic field to control clinically used therapeutic bacteria that have no natural magnetism.

Reference: “Magnetic torque–driven living microrobots for increased tumor infiltration” by T. Gwisai, N. Mirkhani, M. G. Christiansen, T. T. Nguyen, V. Ling and S. Schuerle, 26 October 2022, Science Robotics.
DOI: 10.1126/scirobotics.abo0665

Share

View Comments

  • Does this new approach believe it can attack Stage 4 Metastatic breast cancer to bone and liver? Currently, the Mets in bone has been responding to treatment and stable; however,recently Mets have appeared in liver. To which, ablation and embolization have been the course of treatment thus far and continuing a 2nd round of each when two new tumors appeared on PET scan.
    Do you believe this is something that would benefit and are you currently conducting human clinical trials yet?

By
ETH Zurich

Recent Posts

A Peculiar Case of “Virgin Birth” in Aquarium Sharks

Asexual reproduction is prevalent among animals such as starfish, deep-sea worms, and stick insects, but…

January 28, 2023

Decades-Old Mystery Solved? Astronomers May Have Uncovered How Galaxies Change Their Shape

By using artificial intelligence, researchers have potentially solved a long-standing question about the evolution of…

January 28, 2023

Mysteries Remain About Puzzling Bahamas Whiting Events

Researchers used satellite imagery to reveal where and when the discolored patches of water appeared…

January 28, 2023

Rotating Detonation Rocket Engine: NASA’s Revolutionary Propulsion Design for Deep Space Missions

As NASA takes its first steps toward establishing a long-term presence on the Moon’s surface,…

January 28, 2023

Important Advance in Quantum Science: Coherent Manipulation of Spin Qubits at Room Temperature

A team headed by Professor Wu Kaifeng from the Dalian Institute of Chemical Physics (DICP)…

January 28, 2023

Healthy Plant-Based Diets Could Lower Men’s Risk of Colon Cancer

A diet rich in whole grains, vegetables, and legumes and low in refined grains, fruit…

January 28, 2023